vs
Side-by-side financial comparison of Howard Hughes Holdings Inc. (HHH) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Howard Hughes Holdings Inc. is the larger business by last-quarter revenue ($235.9M vs $158.6M, roughly 1.5× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 3.4%, a 67.8% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 18.4%).
Howard Hughes Holdings Inc., formerly the Howard Hughes Corporation, is a real estate development and management company based in The Woodlands, Texas. It was formed in 2010 as a spin-off from General Growth Properties (GGP). Most of its holdings are focused on several master-planned communities. It took its name from the original Howard Hughes Corporation, which had developed the planned community of Summerlin, Nevada, and later became a subsidiary of GGP.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
HHH vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $235.9M | $158.6M |
| Net Profit | $8.1M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 121.6% | 70.2% |
| Net Margin | 3.4% | 71.2% |
| Revenue YoY | 18.4% | 3661.1% |
| Net Profit YoY | -25.6% | 528.0% |
| EPS (diluted) | $0.14 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $235.9M | — | ||
| Q4 25 | $624.4M | — | ||
| Q3 25 | $390.2M | — | ||
| Q2 25 | $260.9M | — | ||
| Q1 25 | $199.3M | $158.6M | ||
| Q4 24 | $935.0M | $22.6M | ||
| Q3 24 | $327.1M | — | ||
| Q2 24 | $317.4M | — |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $6.0M | — | ||
| Q3 25 | $119.5M | — | ||
| Q2 25 | $-12.1M | — | ||
| Q1 25 | $10.5M | $112.9M | ||
| Q4 24 | $156.3M | $-10.5M | ||
| Q3 24 | $72.8M | — | ||
| Q2 24 | $21.1M | — |
| Q1 26 | 121.6% | — | ||
| Q4 25 | 4.2% | — | ||
| Q3 25 | 48.6% | — | ||
| Q2 25 | 26.0% | — | ||
| Q1 25 | 24.0% | 70.2% | ||
| Q4 24 | 33.5% | -60.4% | ||
| Q3 24 | 60.6% | — | ||
| Q2 24 | 20.4% | — |
| Q1 26 | 3.4% | — | ||
| Q4 25 | 1.0% | — | ||
| Q3 25 | 30.6% | — | ||
| Q2 25 | -4.7% | — | ||
| Q1 25 | 5.3% | 71.2% | ||
| Q4 24 | 16.7% | -46.4% | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | 6.6% | — |
| Q1 26 | $0.14 | — | ||
| Q4 25 | $0.20 | — | ||
| Q3 25 | $2.02 | — | ||
| Q2 25 | $-0.22 | — | ||
| Q1 25 | $0.21 | $1.90 | ||
| Q4 24 | $3.14 | $-0.15 | ||
| Q3 24 | $1.46 | — | ||
| Q2 24 | $0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.8B | $350.1M |
| Total Assets | $11.2B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $493.7M | $274.8M | ||
| Q4 24 | $596.1M | $128.0M | ||
| Q3 24 | $400.7M | — | ||
| Q2 24 | $436.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | $5.1B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $5.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $3.8B | — | ||
| Q4 25 | $3.8B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $2.8B | $350.1M | ||
| Q4 24 | $2.8B | $229.0M | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $3.0B | — |
| Q1 26 | $11.2B | — | ||
| Q4 25 | $10.6B | — | ||
| Q3 25 | $10.7B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $9.3B | $406.9M | ||
| Q4 24 | $9.2B | $271.6M | ||
| Q3 24 | $9.4B | — | ||
| Q2 24 | $9.9B | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.35× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.85× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $360.3M | — | ||
| Q3 25 | $149.8M | — | ||
| Q2 25 | $177.3M | — | ||
| Q1 25 | $-224.9M | $131.8M | ||
| Q4 24 | $337.1M | $-23.2M | ||
| Q3 24 | $248.3M | — | ||
| Q2 24 | $-17.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $348.6M | — | ||
| Q3 25 | $137.7M | — | ||
| Q2 25 | $169.7M | — | ||
| Q1 25 | $-238.4M | $131.7M | ||
| Q4 24 | $317.1M | $-23.2M | ||
| Q3 24 | $238.7M | — | ||
| Q2 24 | $-25.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 55.8% | — | ||
| Q3 25 | 35.3% | — | ||
| Q2 25 | 65.1% | — | ||
| Q1 25 | -119.6% | 83.0% | ||
| Q4 24 | 33.9% | -102.7% | ||
| Q3 24 | 73.0% | — | ||
| Q2 24 | -7.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 6.8% | 0.1% | ||
| Q4 24 | 2.1% | 0.2% | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 2.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 60.04× | — | ||
| Q3 25 | 1.25× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -21.35× | 1.17× | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 3.41× | — | ||
| Q2 24 | -0.83× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HHH
| Rental revenue | $113.5M | 48% |
| Master Planned Communities land sales | $99.6M | 42% |
| Other revenues | $11.0M | 5% |
| Builder price participation | $8.7M | 4% |
| Condominium rights and unit sales | $3.1M | 1% |
STOK
Segment breakdown not available.
